NeurOptics
Private Company
Total funding raised: $20M
Overview
NeurOptics is a commercial-stage medical device company and the worldwide leader in automated pupillometry. Its flagship NPi-300 system delivers objective, numerical data on pupil size and reactivity, addressing the critical need for reliable neurological monitoring in intensive care settings. The technology is already adopted in over 1,000 U.S. hospitals and represented in more than 50 countries, indicating strong market validation. The company is positioned at the intersection of medical devices and digital health, with a focus on integrating pupillometry data into electronic medical records to enhance clinical decision-making.
Technology Platform
Automated pupillometry using dynamic digital infrared technology and a proprietary algorithm to calculate the Neurological Pupil index (NPi), providing objective measurement of pupil size and reactivity.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
NeurOptics is the clear pioneer and market leader in quantitative, algorithmic pupillometry. Competition exists from traditional manual assessment and basic handheld pupil gauges, but few offer the objective NPi metric. Potential future competitors include large patient monitoring companies (e.g., Medtronic, Philips, GE Healthcare) if they choose to integrate similar technology into their multi-parameter monitors.